ProCE Banner Activity

Optimal Management of Moderate to Severe AD in Adults

Slideset Download

Experts review the latest in managing moderate to severe AD in adults, from Clinical Care Options (CCO).

Released: January 13, 2023

Expiration: January 12, 2024

No longer available for credit.

Share

Faculty

Robert Sidbury

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Jonathan Silverberg

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Sanofi Genzyme

Faculty Disclosure

Primary Author

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Robert Sidbury, MD, MPH: consultant/advisor/speaker: Beiersdorf, Leo, Lilly, Micreos; researcher: Castle, Galderma, Pfizer, Regeneron, UCB.

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Jonathan I. Silverberg, MD, PHD, MPH: consultant/advisor: AbbVie, Aobiome, Arcutis, Amgen, Arena, Asana, Aslan, BioMX, Biosion, Bodewell, Boehringer Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo, Lilly, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi, Shaperon, Union.